The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.

A new malaria drug, Ganaplacide/Lumefantrine, shows over 97% cure rates in trials. This treatment is effective even where ...

Trenton M. Johnson is a seasoned project management leader with 27+ years of experience working in the biopharma industry ...

Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...

The decision to pause dapiglutide will help Zealand focus investment into assets that have “the greatest potential for ...

India's Biocon expects a 50% drop in costs for developing complex biosimilars as ​the United States has proposed to ease ...

OneSource Specialty Pharma has raised its FY28 revenue forecast from $400 million to over $500 million, driven by strong ...

RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...

The White House just announced that AstraZeneca and Pfizer will start charging foreign health systems the same prices for all ...

Scientists developed a drug that destroys a cancer protein rather than blocking it, cutting pancreatic tumor growth by half ...

Korro Bio is moving back to square one as a preclinical biotech after the failure of KRRO-110 in alpha-1 antitrypsin ...